Extracellular lactate, a byproduct of glycolysis in low oxygen environments, was found to drive BCR/Ablprotein suppression and thereby to push CML cells endowed with stem cell potential toward a BCR/Abl‐independent phenotype. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.